- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06669728
Study on the Diagnostic Efficacy of ICL Selection and Prediction Depth Model Based on Eye Images
April 21, 2026 updated by: Jian Xiong, Second Affiliated Hospital of Nanchang University
Diagnostic Efficacy of Deep Neural Network Algorithm Based on Preoperative Scheimpflug-based Anterior Segment Image for Implantable Collamer Lens Selection and Prediction
To evaluate the diagnostic efficacy of deep learning network model in implantable collamer lens selection and prediction in a multicenter cross-sectional study
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Posterior chamber intraocular lens implantation is an main choice for myopia correction.
Implantable collamer lens (ICL) is currently the most widely used, and the official reference index is mainly based on biological parameters obtained from eye images.
The parameter acquisition and selection of ICL design are often controversial, forcing the doctors to synthesize multiple modal data, making the optimization of ICL formula being a focus of attention in refractive surgery.
This research aimed to build an image-based ICL prediction algorithm to assist human physicians in decision-making and improve the accuracy, safety and predictability of ICL implantation.
Study Type
Observational
Enrollment (Estimated)
326
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jian Xiong doctor
- Phone Number: +8618170906556
- Email: 894040417@qq.com
Study Contact Backup
- Name: Fu Gui docter
- Phone Number: +8613879101919
- Email: 564436578@qq.com
Study Locations
-
-
Jiangxi
-
Nanchang, Jiangxi, China, 330000
- Recruiting
- The Second Affiliated Hospital of Nanchang University
-
Contact:
- Jian Xiong doctor
- Phone Number: +8618170906556
- Email: 894040417@qq.com
-
Contact:
- Fu Gui doctor
- Phone Number: +8613879101919
- Email: 564436578@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Patients from clinics in different eye centers across China.
Each subject must with complete surgical video recording and medical records.
Description
Inclusion Criteria:
- Aged 18-45 years ;
- Myopia, with or without astigmatism, annual diopter change ≤ 0.50 D for 2 consecutive years ;
- Anterior chamber depth ≥ 2.80 mm ;
- Corneal endothelial cell count ≥ 2000 / mm2, stable cell morphology ;
- There were no other ocular diseases that significantly affected vision and / or systemic organic lesions that affected surgical recovery.
Exclusion Criteria:
- There were no other ocular diseases that significantly affected vision and / or systemic organic lesions that affected surgical recovery;
- Have a history of corneal refractive surgery or intraocular surgery ;
- Corneal endothelial cell count is low ;
- Those with systemic diseases ;
- Lactating or pregnant women.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Eyes with ICL surgeries
Eyes with SMILE surgeries which were performed by surgeons with experiences.
|
The ICL procedures collected would be assessed by the algorithm.
The performance of the algorithm would be assessed, including accuracy, AUC, sensitivity and specificity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
AUROC of convolutional neural network in predicting vault after ICL surgery
Time Frame: Day 7
|
The area under the receiver operating characteristic of convolutional neural network in predicting vault after ICL surgery
|
Day 7
|
|
AUROC of convolutional neural network in predicting anterior chamber angle after ICL implantation
Time Frame: Day 7
|
The area under the receiver operating characteristic of convolutional neural network in predicting anterior chamber angle after ICL implantation
|
Day 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity and specificity of convolutional neural network in predicting Vault after ICL implantation
Time Frame: Day 7
|
Sensitivity and specificity of convolutional neural network in predicting Vault after ICL implantation
|
Day 7
|
|
Sensitivity and specificity of convolutional neural network in predicting anterior chamber angle after ICL implantation
Time Frame: Day 7
|
Sensitivity and specificity of convolutional neural network in predicting anterior chamber angle after ICL implantation
|
Day 7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 2, 2021
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
August 31, 2027
Study Registration Dates
First Submitted
October 30, 2024
First Submitted That Met QC Criteria
October 30, 2024
First Posted (Actual)
November 1, 2024
Study Record Updates
Last Update Posted (Actual)
April 24, 2026
Last Update Submitted That Met QC Criteria
April 21, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- [2024] NO.(93)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on AI diagnostic algorithm
-
Second Affiliated Hospital of Nanchang UniversityHangzhou Huaxia Eye Hospital; Nanchang Bright Eye HospitalRecruitingIntraoperative Complications | Postoperative Outcomes | Small-incision Lenticule Extraction (SMILE) Surgery | Deep Convolutional Neural NetworkChina
-
Sun Yat-sen UniversityCompletedDiagnositic Efficacy of Deep Convolutional Neural Network in Differentiation of Glaucoma Visual Field From Non-glaucoma Visual FieldChina
-
Kıvanç AkçaHacettepe UniversityCompleted
-
Shanghai Jiao Tong University Affiliated Sixth...RecruitingAcute Ischemic Stroke | CT Angiography | Endovascular Thrombectomy | Artificial Intelligence (AI)China
-
Universitair Ziekenhuis BrusselRecruiting
-
Tri-Service General HospitalNot yet recruiting
-
Heart Input Output IncNot yet recruitingAI-algorithm UsageUnited States
-
Mayo ClinicCompletedCardiac AmyloidosisUnited States
-
Techcyte, Inc.Enrolling by invitationCervical Cytology | PAPUnited States
-
University Hospital Center of MartiniquePfizerUnknownCardiac AmyloidosisGuadeloupe, Martinique